Alibhai S - Search Results

1

Active surveillance in patients with a PSA >10 ng/mL.

Toren P, Wong LM, Timilshina N, Alibhai S, Trachtenberg J, Fleshner N, Finelli A. Toren P, et al. Among authors: alibhai s. Can Urol Assoc J. 2014 Sep;8(9-10):E702-7. doi: 10.5489/cuaj.2121. Can Urol Assoc J. 2014. PMID: 25408810 Free PMC article.

2

Do older men benefit from curative therapy of localized prostate cancer?

Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD. Alibhai SM, et al. J Clin Oncol. 2003 Sep 1;21(17):3318-27. doi: 10.1200/JCO.2003.09.034. J Clin Oncol. 2003. PMID: 12947068

3

Is there age bias in the treatment of localized prostate carcinoma?

Alibhai SM, Krahn MD, Cohen MM, Fleshner NE, Tomlinson GA, Naglie G. Alibhai SM, et al. Cancer. 2004 Jan 1;100(1):72-81. doi: 10.1002/cncr.11884. Cancer. 2004. PMID: 14692026 Free article.

4

The association between patient age and prostate cancer stage and grade at diagnosis.

Alibhai SM, Krahn MD, Fleshner NE, Cohen MM, Tomlinson GA, Naglie G. Alibhai SM, et al. BJU Int. 2004 Aug;94(3):303-6. doi: 10.1111/j.1464-410X.2004.04883.x. BJU Int. 2004. PMID: 15291856

5

30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.

Alibhai SM, Leach M, Tomlinson G, Krahn MD, Fleshner N, Holowaty E, Naglie G. Alibhai SM, et al. J Natl Cancer Inst. 2005 Oct 19;97(20):1525-32. doi: 10.1093/jnci/dji313. J Natl Cancer Inst. 2005. PMID: 16234566

6

Rethinking 30-day mortality risk after radical prostatectomy.

Alibhai SM, Leach M, Tomlinson G, Krahn MD, Fleshner N, Naglie G. Alibhai SM, et al. Urology. 2006 Nov;68(5):1057-60. doi: 10.1016/j.urology.2006.06.016. Urology. 2006. PMID: 17113897

7

Optimal management of high-risk T1G3 bladder cancer: a decision analysis.

Kulkarni GS, Finelli A, Fleshner NE, Jewett MA, Lopushinsky SR, Alibhai SM. Kulkarni GS, et al. Among authors: alibhai sm. PLoS Med. 2007 Sep;4(9):e284. doi: 10.1371/journal.pmed.0040284. PLoS Med. 2007. PMID: 17896857 Free PMC article.

8

Is there an optimal comorbidity index for prostate cancer?

Alibhai SM, Leach M, Tomlinson GA, Krahn MD, Fleshner NE, Naglie G. Alibhai SM, et al. Cancer. 2008 Mar 1;112(5):1043-50. doi: 10.1002/cncr.23269. Cancer. 2008. PMID: 18286512 Free article.

9

Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer.

Panju AH, Breunis H, Cheung AM, Leach M, Fleshner N, Warde P, Duff-Canning S, Krahn M, Naglie G, Tannock I, Tomlinson G, Alibhai SM. Panju AH, et al. Among authors: alibhai sm. BJU Int. 2009 Mar;103(6):753-7. doi: 10.1111/j.1464-410X.2008.08156.x. Epub 2008 Oct 24. BJU Int. 2009. PMID: 19007370 Free PMC article.

10

Impact of androgen deprivation therapy on cardiovascular disease and diabetes.

Alibhai SM, Duong-Hua M, Sutradhar R, Fleshner NE, Warde P, Cheung AM, Paszat LF. Alibhai SM, et al. J Clin Oncol. 2009 Jul 20;27(21):3452-8. doi: 10.1200/JCO.2008.20.0923. Epub 2009 Jun 8. J Clin Oncol. 2009. PMID: 19506162 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

446 results

Search Page

Filters